What was Calumet Inc (CLMT)’s performance in the last session?

While Calumet Inc has underperformed by -0.38%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CLMT fell by -28.29%, with highs and lows ranging from $25.29 to $7.68, whereas the simple moving average fell by -5.03% in the last 200 days.

On May 13, 2025, BofA Securities started tracking Calumet Inc (NASDAQ: CLMT) recommending Buy. A report published by UBS on March 17, 2025, Upgraded its rating to ‘Neutral’ for CLMT. TD Cowen also Downgraded CLMT shares as ‘Hold’, setting a target price of $16 on the company’s shares in a report dated March 04, 2025. UBS February 04, 2025d the rating to Sell on February 04, 2025, and set its price target from $20.50 to $15. TD Cowen resumed its ‘Buy’ rating for CLMT, as published in its report on November 11, 2024. TD Cowen’s report from October 17, 2024 suggests a price prediction of $27 for CLMT shares, giving the stock a ‘Buy’ rating. TD Cowen also rated the stock as ‘Buy’.

Analysis of Calumet Inc (CLMT)

Further, the quarter-over-quarter decrease in sales is -1.18%, showing a negative trend in the upcoming months.

In order to gain a clear picture of Calumet Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. Taking into account the quick ratio of the company, currently set at 0.61, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

An average volume of 1.14M can be a very valuable indicator of volatility for CLMT stock. On a monthly basis, the volatility of the stock is set at 3.68%, whereas on a weekly basis, it is put at 1.51%, with a loss of -6.35% over the past seven days. Furthermore, long-term investors anticipate a median target price of $20.40, showing growth from the present price of $15.79, which can serve as yet another indication of whether CLMT is worth investing in or should be passed over.

How Do You Analyze Calumet Inc Shares?

In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 20.21%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 45.85% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

CLMT shares are owned by institutional investors to the tune of 45.85% at present.

Hot this week

How to interpret Westwater Resources Inc (WWR)’s stock chart patterns

While Westwater Resources Inc has overperformed by 2.25%, investors...

Helmerich & Payne, Inc (HP) stock on the rise: An overview

While Helmerich & Payne, Inc has underperformed by -2.51%,...

What technical indicators reveal about CDNA stock

While Caredx Inc has underperformed by -0.37%, investors are...

Cosan S.A ADR (CSAN) stock analysis: A simple moving average approach

While Cosan S.A ADR has overperformed by 2.78%, investors...

Sweetgreen Inc (SG)’s highs and lows: A closer look at its stock price fluctuations

While Sweetgreen Inc has overperformed by 3.98%, investors are...

Topics

How to interpret Westwater Resources Inc (WWR)’s stock chart patterns

While Westwater Resources Inc has overperformed by 2.25%, investors...

Helmerich & Payne, Inc (HP) stock on the rise: An overview

While Helmerich & Payne, Inc has underperformed by -2.51%,...

What technical indicators reveal about CDNA stock

While Caredx Inc has underperformed by -0.37%, investors are...

Cosan S.A ADR (CSAN) stock analysis: A simple moving average approach

While Cosan S.A ADR has overperformed by 2.78%, investors...

Sweetgreen Inc (SG)’s highs and lows: A closer look at its stock price fluctuations

While Sweetgreen Inc has overperformed by 3.98%, investors are...

A year in review: Calidi Biotherapeutics Inc (CLDI)’s performance in the last year

While Calidi Biotherapeutics Inc has underperformed by -8.74%, investors...

CAR overperforms with a 16.91% increase in share price

While Avis Budget Group Inc has overperformed by 16.91%,...

Technical analysis of NioCorp Developments Ltd (NB) stock chart patterns

While NioCorp Developments Ltd has underperformed by -7.04%, investors...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.